264 related articles for article (PubMed ID: 17709727)
1. Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
Iddings DM; Koda EA; Grewal SS; Parker R; Saha S; Bilchik A
Arch Surg; 2007 Aug; 142(8):738-44; discussion 744-5. PubMed ID: 17709727
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
[TBL] [Abstract][Full Text] [Related]
3. Independent association of angiogenesis index with outcome in prostate cancer.
Mehta R; Kyshtoobayeva A; Kurosaki T; Small EJ; Kim H; Stroup R; McLaren CE; Li KT; Fruehauf JP
Clin Cancer Res; 2001 Jan; 7(1):81-8. PubMed ID: 11205922
[TBL] [Abstract][Full Text] [Related]
4. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
Ohta Y; Shridhar V; Kalemkerian GP; Bright RK; Watanabe Y; Pass HI
Cancer; 1999 Jun; 85(12):2570-6. PubMed ID: 10375104
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
9. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
[TBL] [Abstract][Full Text] [Related]
10. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
11. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
[TBL] [Abstract][Full Text] [Related]
12. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
[TBL] [Abstract][Full Text] [Related]
14. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
15. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
16. Isolated tumor cells in breast cancer sentinel lymph nodes: displacement or metastases? An immunohistochemical study.
van Deurzen CH; de Bruin PC; Koelemij R; Hillegersberg R; van Diest PJ
Hum Pathol; 2009 Jun; 40(6):778-82. PubMed ID: 19200573
[TBL] [Abstract][Full Text] [Related]
17. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
18. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
[TBL] [Abstract][Full Text] [Related]
19. The alteration of Id-1 and TSP-1 expression in mucoepidermoid carcinoma associated with its clinical features and prognosis.
Yang S; Guo LJ; Tang XF; Tan K; Gong RG; Li A; Yu T; Gao QH; Xuan M; Wen YM; Wang CM; Wang XY
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):29-35. PubMed ID: 19906510
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.
Clarke G; Ryan E; Crowe J; O'Keane JC; MacMathúna P
Eur J Histochem; 1999; 43(4):311-6. PubMed ID: 10682269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
